About Neurolytixs
Neurolytixs is a company based in Toronto (Canada) founded in 2020 by Douglas Fraser and Adrian Uthay. Neurolytixs operates in a competitive market with competitors including Nuada Medical, Telradsol, Rapid Rad, Tongling Bionic and Burgess Diagnostics, among others.
- Headquarter Toronto, Canada
- Founders Douglas Fraser, Adrian Uthay
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Neurolytixs
Detailed funding history for Neurolytixs
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Neurolytixs
Investment portfolio details for Neurolytixs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Neurolytixs
Detailed financials for Neurolytixs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Neurolytixs Comparisons
Peer comparison for Neurolytixs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Neurolytixs
Neurolytixs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nuada Medical, Telradsol, Rapid Rad, Tongling Bionic and Burgess Diagnostics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Outsourced medical imaging services are provided to healthcare clients.
|
|
| Locked | Locked | Locked |
Provides remote radiology reading, AI workflows, and diagnostic support for medical institutions.
|
|
| Locked | Locked | Locked |
Provides remote radiology services to hospitals and imaging centers with 24/7 coverage.
|
|
| Locked | Locked | Locked |
Provider of integrated solutions for diagnosis and treatment for heart failure patients
|
|
| Locked | Locked | Locked |
Outsourced veterinary radiology services are provided by Burgess Diagnostics.
|
Detailed competitors of Neurolytixs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Neurolytixs
Complete news archive for Neurolytixs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neurolytixs
Neurolytixs was founded in 2020.
Neurolytixs is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
Neurolytixs was founded in 2020 and is based in Toronto, Canada. Operations focus on the health technology sector, where artificial intelligence is applied to analyze blood biomarkers for concussion detection. Services include diagnostic testing and AI-driven assessments to support medical evaluations. The company is led by founder Douglas Fraser and co-founder Adrian Uthay, with activities centered on advancing neurological diagnostics through biomarker innovation.
Neurolytixs's top competitors include Nuada Medical, Golden State Medicare Health Plan and Caire Health Holdings.